EcoDrugPlus

Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 8

Ensembl ID : ENSMAMG00000019791
Gene Symbol: CACNG8
3 Cross references
159 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 D

Ensembl ID : ENSMAMG00000016878
Gene Symbol: CACNA1D
3 Cross references
208 Possible Orthologues:

Calcium-Sensing Receptor

Ensembl ID : ENSMAMG00000017580
Gene Symbol: CASR
2 Cross references
202 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSMAMG00000003960
Gene Symbol: CNR1
3 Cross references
150 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSMAMG00000027709
Gene Symbol: CNR1
3 Cross references
134 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSMAMG00000008073
Gene Symbol: CNR2
3 Cross references
191 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSMAMG00000007184
Gene Symbol: CA12
3 Cross references
214 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSMAMG00000021162
Gene Symbol: LOC113142791
3 Cross references
79 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSMAMG00000010160
Gene Symbol: CA6
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSMAMG00000006393
Gene Symbol: CA4A
3 Cross references
212 Possible Orthologues:

Carbonic Anhydrase Iv B

Ensembl ID : ENSMAMG00000018731
Gene Symbol: CA4B
2 Cross references
196 Possible Orthologues:

Carbonic Anhydrase Vii

Ensembl ID : ENSMAMG00000002369
Gene Symbol: CA7
3 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).